S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
Log in

CV Sciences Stock Forecast, Price & News

0.00 (0.00 %)
(As of 01/20/2021 12:00 AM ET)
Today's Range
Now: $0.60
50-Day Range
MA: $0.54
52-Week Range
Now: $0.60
Volume736,332 shs
Average Volume1.32 million shs
Market Capitalization$60.98 million
P/E RatioN/A
Dividend YieldN/A
CV Sciences, Inc. operates as a life science company. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets hemp-based cannabidiol (CBD) products under the name of PlusCBD in a range of market sectors, including nutraceutical, beauty care, and specialty foods. It serves internet sales, direct-to-consumer health and wellness stores, collectives, cooperatives, master distributors, specialty retailers, and convenience stores, as well as food, drug, and mass merchandise retailers. The Specialty Pharmaceutical segment focuses on developing and commercializing cannabinoids to treat medical indications. Its products product candidates are based on proprietary formulations, processes, and technology. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.


Overall MarketRank

1.30 out of 5 stars

Medical Sector

697th out of 1,928 stocks

Pharmaceutical Preparations Industry

352nd out of 774 stocks

Analyst Opinion: 3.3Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:CVSI
Previous SymbolNASDAQ:CVSI



Sales & Book Value

Annual Sales$53.70 million
Book Value$0.29 per share


Net Income$-16,610,000.00


Market Cap$60.98 million
Next Earnings Date3/15/2021 (Estimated)
OptionableNot Optionable
0.00 (0.00 %)
(As of 01/20/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CVSI News and Ratings via Email

Sign-up to receive the latest news and ratings for CVSI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

CV Sciences (OTCMKTS:CVSI) Frequently Asked Questions

How has CV Sciences' stock been impacted by Coronavirus (COVID-19)?

CV Sciences' stock was trading at $0.60 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CVSI stock has decreased by 0.6% and is now trading at $0.5965.
View which stocks have been most impacted by COVID-19

Is CV Sciences a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CV Sciences in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CV Sciences stock.
View analyst ratings for CV Sciences
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than CV Sciences?

Wall Street analysts have given CV Sciences a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CV Sciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is CV Sciences' next earnings date?

CV Sciences is scheduled to release its next quarterly earnings announcement on Monday, March 15th 2021.
View our earnings forecast for CV Sciences

How were CV Sciences' earnings last quarter?

CV Sciences, Inc. (OTCMKTS:CVSI) issued its earnings results on Thursday, November, 5th. The company reported ($0.03) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.02) by $0.01. The company had revenue of $5.56 million for the quarter, compared to analyst estimates of $6.32 million. CV Sciences had a negative net margin of 68.90% and a negative return on equity of 81.99%.
View CV Sciences' earnings history

What price target have analysts set for CVSI?

4 analysts have issued 1-year price targets for CV Sciences' shares. Their forecasts range from $0.75 to $1.70. On average, they expect CV Sciences' stock price to reach $1.13 in the next twelve months. This suggests a possible upside of 90.0% from the stock's current price.
View analysts' price targets for CV Sciences
or view Wall Street analyst' top-rated stocks.

Are investors shorting CV Sciences?

CV Sciences saw a decline in short interest in December. As of December 31st, there was short interest totaling 847,300 shares, a decline of 30.6% from the December 15th total of 1,220,300 shares. Based on an average daily trading volume, of 1,922,600 shares, the days-to-cover ratio is currently 0.4 days.
View CV Sciences' Short Interest

Who are some of CV Sciences' key competitors?

What other stocks do shareholders of CV Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CV Sciences investors own include (CGC), Aurora Cannabis (ACB), Cronos Group (CRON), Charlotte's Web (CWBHF), KushCo (KSHB), (APHA), OrganiGram (OGI), GW Pharmaceuticals (GWPH), Tilray (TLRY) and Medical Marijuana (MJNA).

Who are CV Sciences' key executives?

CV Sciences' management team includes the following people:
  • Mr. Joseph D. Dowling, CEO, Sec. & Director (Age 63, Pay $708.77k)
  • Mr. Joerg Grasser, Chief Financial Officer (Age 45, Pay $389.23k)
  • Dr. Douglas Jesse MacKay ND, Sr. VP of Scientific & Regulatory Affairs (Age 47)

What is CV Sciences' stock symbol?

CV Sciences trades on the OTCMKTS under the ticker symbol "CVSI."

How do I buy shares of CV Sciences?

Shares of CVSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CV Sciences' stock price today?

One share of CVSI stock can currently be purchased for approximately $0.60.

How big of a company is CV Sciences?

CV Sciences has a market capitalization of $60.98 million and generates $53.70 million in revenue each year. The company earns $-16,610,000.00 in net income (profit) each year or ($0.17) on an earnings per share basis. CV Sciences employs 118 workers across the globe.

What is CV Sciences' official website?

The official website for CV Sciences is www.cvsciences.com.

How can I contact CV Sciences?

CV Sciences' mailing address is 10070 BARNES CANYON ROAD, SAN DIEGO CA, 92121. The company can be reached via phone at 866-290-2157 or via email at [email protected]

This page was last updated on 1/21/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.